Skip to main content
OpenTrials

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

NCT03961555

Conditions
Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Clinical Research Solutions PC -Milan Milan, Tennessee, United States
  • University of Virginia Charlottesville, Virginia, United States
View all 14 locations
View Trial Details
Completed

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

NCT06614725

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Kanpur, Uttar Pradesh, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Aligarh, India
View all 14 locations
View Trial Details
Completed

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

NCT05268939

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Diagnamics, Inc Encinitas, California, United States
  • Marisela Gonzalez, MD, PA Miami, Florida, United States
  • Excellence Medical and Research Miami Gardens, Florida, United States
View Trial Details
Completed

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

NCT04782336

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +19 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • NHS Lothian - Royal Hospital for Children & Young People Edinburgh, United Kingdom
  • Leicester Royal Infirmary Leicester, United Kingdom
  • Barts Health NHS Trust London, United Kingdom
View Trial Details
Completed

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921

Conditions
Infections, Influenza, Human, Mononegavirales Infections, +8 more
Locations
  • MedHelp Urgent Care Birmingham, Alabama, United States
  • Access Medical Center Encinitas, California, United States
  • Madera Family Medical Group Madera, California, United States
  • ImmunoE Health and Research Centennial, Colorado, United States
View all 20 locations
View Trial Details
Completed

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

NCT05921903

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Lexington, Kentucky, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
View all 46 locations
View Trial Details
Completed

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

NCT06551181

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Shanghai, Putuo, China
  • GSK Investigational Site Shanghai, Putuo, China
  • GSK Investigational Site Shanghai, Shanghai Municipality, China
  • GSK Investigational Site Shanghai, China
View all 40 locations
View Trial Details

Related conditions